|
1
|
Mazzanti R, Arena U and Tassi R:
Hepatocellular carcinoma: Where are we? World J Exp Med. 6:21–36.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bruix J, Reig M and Sherman M:
Evidence-based diagnosis, staging, and treatment of patients with
hepatocellular carcinoma. Gastroenterology. 150:835–853. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yi PS, Zhang M and Xu MQ: Management of
the middle hepatic vein in right lobe living donor liver
transplantation: A meta-analysis. J Huazhong Univ Sci Technolog Med
Sci. 35:600–605. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Llovet JM, Bru C and Bruix J: Prognosis of
hepatocellular carcinoma: The BCLC staging classification. Semin
Liver Dis. 19:329–338. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J
Med. 359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu MD, Jia LH, Liu HB, Zhang KH and Guo
GH: Sorafenib in combination with transarterial chemoembolization
for hepatocellular carcinoma: A meta-analysis. Eur Rev Med
Pharmacol Sci. 20:64–74. 2016.PubMed/NCBI
|
|
7
|
Yuan SX, Yang F, Yang Y, Tao QF, Zhang J,
Huang G, Yang Y, Wang RY, Yang S, Huo XS, et al: Long noncoding RNA
associated with microvascular invasion in hepatocellular carcinoma
promotes angiogenesis and serves as a predictor for hepatocellular
carcinoma patients' poor recurrence-free survival after
hepatectomy. Hepatology. 56:2231–2241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Silva FP, Hamamoto R, Furukawa Y and
Nakamura Y: TIPUH1 encodes a novel KRAB zinc-finger protein highly
expressed in human hepatocellular carcinomas. Oncogene.
25:5063–5070. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Q, Tan YX, Ren YB, Dong LW, Xie ZF,
Tang L, Cao D, Zhang WP, Hu HP and Wang HY: Zinc finger protein
ZBTB20 expression is increased in hepatocellular carcinoma and
associated with poor prognosis. BMC Cancer. 11:2712011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kan H, Huang Y, Li X, Liu D, Chen J and
Shu M: Zinc finger protein ZBTB20 is an independent prognostic
marker and promotes tumor growth of human hepatocellular carcinoma
by repressing FoxO1. Oncotarget. 7:14336–14349. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Z, Sun B, Li Y, Zhao X, Zhao X, Gu Q,
An J, Dong X, Liu F and Wang Y: ZEB2 promotes vasculogenic mimicry
by TGF-β1 induced epithelial-to-mesenchymal transition in
hepatocellular carcinoma. Exp Mol Pathol. 98:352–359. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu D, Liu G, Liu Y, Saiyin H, Wang C, Wei
Z, Zen W, Liu D, Chen Q, Zhao Z, et al: Zinc finger protein 191
inhibits hepatocellular carcinoma metastasis through discs large
1-mediated yes-associated protein inactivation. Hepatology.
64:1148–1162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shigematsu S, Fukuda S, Nakayama H, Inoue
H, Hiasa Y, Onji M and Higashiyama S: ZNF689 suppresses apoptosis
of hepatocellular carcinoma cells through the down-regulation of
Bcl-2 family members. Exp Cell Res. 317:1851–1859. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang BG, Wan ZH, Huang J, Li LM, Liu H,
Fu SY, Yang Y, Zhang J, Yuan SX, Wang RY, et al: Elevated ZC3H15
increases HCC growth and predicts poor survival after surgical
resection. Oncotarget. 7:37238–37249. 2016.PubMed/NCBI
|
|
15
|
Papatheodoridis GV, Cholongitas E,
Dimitriadou E, Touloumi G, Sevastianos V and Archimandritis AJ:
MELD vs Child-Pugh and creatinine-modified Child-Pugh score for
predicting survival in patients with decompensated cirrhosis. World
J Gastroenterol. 11:3099–3104. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Specht E, Kaemmerer D, Sanger J, Wirtz RM,
Schulz S and Lupp A: Comparison of immunoreactive score, HER2/neu
score and H score for the immunohistochemical evaluation of
somatostatin receptors in bronchopulmonary neuroendocrine
neoplasms. Histopathology. 67:368–377. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu W, Liu H, Liu ZG, Wang HS, Zhang F,
Wang H, Zhang J, Chen JJ, Huang HJ, Tan Y, et al: Histone
deacetylase inhibitors upregulate Snail via Smad2/3 phosphorylation
and stabilization of Snail to promote metastasis of hepatoma cells.
Cancer Lett. 420:1–13. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu W, Fu J, Lu SX, Liu LL, Luo RZ, Yun JP
and Zhang CZ: Decrease of Bcl-xL/Bcl-2-associated death promoter in
hepatocellular carcinoma indicates poor prognosis. Am J Cancer Res.
5:1805–1813. 2015.PubMed/NCBI
|
|
20
|
Li K, Xyu Q, Liu X, Liu Q and Wang M:
Growth inhibition of human hepatocellular carcinoma by miRNA-204
via down-regulation of Bcl-2 and Sirt1 expression. Xi Bao Yu Fen Zi
Mian Yi Xue Za Zhi. 31:168–172. 2015.(In Chinese). PubMed/NCBI
|
|
21
|
Yu YQ, Wang L, Jin Y, Zhou JL, Geng YH,
Jin X, Zhang XX, Yang JJ, Qian CM, Zhou DE, et al: Identification
of serologic biomarkers for predicting microvascular invasion in
hepatocellular carcinoma. Oncotarget. 7:16362–16371.
2016.PubMed/NCBI
|
|
22
|
Shen J, Wen J, Li C, Wen T, Yan L, Li B,
Yang J and Lu C: The prognostic value of microvascular invasion in
early-intermediate stage hepatocelluar carcinoma: A propensity
score matching analysis. BMC Cancer. 18:2782018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Giannini EG, Bucci L, Garuti F, Brunacci
M, Lenzi B, Valente M, Caturelli E, Cabibbo G, Piscaglia F, Virdone
R, et al: Patients with advanced hepatocellular carcinoma need a
personalized management: A lesson from clinical practice.
Hepatology. 67:1784–1796. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Imai K, Yamashita YI, Yusa T, Nakao Y,
Itoyama R, Nakagawa S, Okabe H, Chikamoto A, Ishiko T and Baba H:
Microvascular invasion in small-sized hepatocellular carcinoma:
Significance for outcomes following hepatectomy and radiofrequency
ablation. Anticancer Res. 38:1053–1060. 2018.PubMed/NCBI
|
|
25
|
Schlichtemeier SM, Pang TC, Williams NE,
Gill AJ, Smith RC, Samra JS, Lam VW, Hollands M, Richardson AJ,
Pleass HC, et al: A pre-operative clinical model to predict
microvascular invasion and long-term outcome after resection of
hepatocellular cancer: The Australian experience. Eur J Surg Oncol.
42:1576–1583. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iguchi T, Aishima S, Taketomi A, Nishihara
Y, Fujita N, Sanefuji K, Maehara Y and Tsuneyoshi M: Extracapsular
penetration is a new prognostic factor in human hepatocellular
carcinoma. Am J Surg Pathol. 32:1675–1682. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iguchi T, Aishima S, Sanefuji K, Fujita N,
Sugimachi K, Gion T, Taketomi A, Shirabe K, Maehara Y and
Tsuneyoshi M: Both fibrous capsule formation and extracapsular
penetration are powerful predictors of poor survival in human
hepatocellular carcinoma: A histological assessment of 365 patients
in Japan. Ann Surg Oncol. 16:2539–2546. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Y, Xu D, Bao C, Zhang Y, Chen D, Zhao
F, Ding J, Liang L, Wang Q, Liu L, et al: MicroRNA-135b, a HSF1
target, promotes tumor invasion and metastasis by regulating RECK
and EVI5 in hepatocellular carcinoma. Oncotarget. 6:2421–2433.
2015.PubMed/NCBI
|
|
29
|
Brabletz T: Metastasis: EMT, microRNAs and
cancer stem cells. Clin Experimental Metastasis. 32:187. 2015.
|
|
30
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang JD, Nakamura I and Roberts LR: The
tumor microenvironment in hepatocellular carcinoma: Current status
and therapeutic targets. Semin Cancer Biol. 21:35–43. 2011.
View Article : Google Scholar : PubMed/NCBI
|
